Page 1 of Clinical Trials for Lymphadenopathy, 98 Total Matches
- 1RecruitingLast Updated: May 11, 2010Condition(s): Mediastinal Lymphadenopathy; Tuberculous Mediastinal Lymphadenopathy
- 2CompletedLast Updated: June 27, 2011Condition(s): Lymphadenopathy; Malignancy
- 3Active, not recruitingLast Updated: October 17, 2011Condition(s): Isolated Mediastinal Lymphadenopathy; Sarcoidosis; Tuberculosis; Lung Cancer; Lymphoma
- 4CompletedLast Updated: May 25, 2010Condition(s): Lymphadenopathy
- 5RecruitingLast Updated: December 15, 2011Condition(s): Mediastinal Lymphadenopathy; Lung Cancer
- 6RecruitingLast Updated: November 7, 2011Condition(s): Mediastinal Lymphadenopathy; Hilar Lymphadenopathy; Carcinoma; Lymphoma; Sarcoidosis; Mycobacterial Disease
- 7CompletedLast Updated: April 24, 2012Condition(s): HIV Infections
- 8RecruitingLast Updated: June 6, 2011Condition(s): Mediastinal Lymphadenopathy
- 9RecruitingLast Updated: January 31, 2012Condition(s): Lymphoma; Kikuchi's Disease
- 10CompletedLast Updated: June 23, 2005Condition(s): Lymphatic Disease; HIV Infections
- 11Active, not recruitingLast Updated: October 17, 2011Condition(s): Lymphadenopathy
- 12CompletedLast Updated: June 23, 2005Condition(s): Lymphatic Disease; HIV Infections
- 13CompletedLast Updated: June 23, 2005Condition(s): Lymphatic Disease; HIV Infections
- 14CompletedLast Updated: January 25, 2012Condition(s): ALPS; Hypersplenism; Lymphadenopathy
- 15Active, not recruitingLast Updated: September 30, 2010Condition(s): Mediastinal or Intra-abdominal Lymphadenopathy,; Pancreatic Masses,; Left Adrenal Masses,; Gastrointestinal Submucosal Lesions, and; Liver Masses
- 16CompletedLast Updated: February 18, 2010Condition(s): Lung Cancer; Sarcoidosis; Tuberculosis
- 17CompletedLast Updated: June 23, 2005Condition(s): HIV Infections
- 18RecruitingLast Updated: October 24, 2011Condition(s): Mediastinal Lymphadenopathies; Mediastinal Masses; Hilar Lymphadenopathies
- 19CompletedLast Updated: April 25, 2012Condition(s): HIV Infections
- 20RecruitingImmunotherapy in Peripheral T Cell Lymphoma - the Role of Alemtuzumab in Addition to Dose Dense CHOPLast Updated: May 4, 2012Condition(s): Peripheral T Cell Lymphoma, Unspecified; Angioimmunoblastic Lymphadenopathy; Extranodal NK/T-cell Lymphoma
Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.
The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=Lymphadenopathy
